Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on July 14, 2008
Chest, doi:10.1378/chest.08-0520
A more recent version of this article appeared on October 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.08-0520v1
134/4/746    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Casanova, C.
Right arrow Articles by Celli, B. R
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casanova, C.
Right arrow Articles by Celli, B. R

DISTANCE AND OXYGEN DESATURATION DURING SIX-MINUTE WALK TEST AS PREDICTORS OF LONG-TERM MORTALITY IN PATIENTS WITH COPD

Ciro Casanova; Claudia Cote; José M. Marin; Víctor Pinto-Plata; Juan P de Torres; Armando Aguirre-Jaíme; Carlos Vassaux and Bartolome R Celli

(1) Pulmonary Department and (2) Research Unit, Hospital La Candelaria, Tenerife and (4) Pulmonary Department, Hospital Miguel Servet, Zaragoza, Spain. (3) Pulmonary Division, Bay Pines VA Medical Center, St Petersburg FL and (5) Pulmonary Division. Caritas-St. Elizabeth's Medical Center, Boston, USA

ccasanova{at}canarias.org

Abstract

RationaleThe distance walked in the 6-minute walk test (6MWT) predicts mortality in patients with severe COPD. Little is known about its prognostic value in patients with a wider range of COPD severity, living in different countries and the potential additional impact of oxygen desaturation measured during the test.

MethodsWe enrolled 576 stable COPD outpatients in Spain and the United States of America, and followed them for at least three years (median 60 months). We measured FEV1, BMI, PaO2, the Charlson co-morbidity score and distance walked (6MWD) and O2 saturation (SpO2) during the 6MWT. Desaturation was defined as a fall in SpO2 ≥4% or Sp02 <90%. Regression analyses helped determine the association between these variables and all cause and respiratory mortality.

ResultsThe 6MWD was a good predictor of all-cause and respiratory mortality primarily in patients with FEV1 <50% (p <0.001) after adjusting for all the co-variates. Patients who desaturated during the 6MWT had a higher mortality than patients who did not desaturate (67% vs 38%, p <0.001). Oxygen desaturation predicted mortality (RR 2.63; 95%CI: 1.53-4.51, p <0.001), but with less power than PaO2 at rest.

ConclusionsThe 6MWD helps predict mortality primarily in patients with severe COPD. Although the oxygen desaturation profile during the 6MWT improves the predictive ability of the 6MWD, it appears to be of less relevance than in other lung diseases and than the resting PaO2.

Key Words: COPD • 6-minute walk test • long-term mortality







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American College of Chest Physicians.